e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
French programme 2020: Part I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
P. Burgel (Sorbonne Paris Cité, France)
Source:
Virtual Congress 2020 – French programme 2020: Part I
Session:
French programme 2020: Part I
Session type:
Language session
Number:
4558
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Burgel (Sorbonne Paris Cité, France). Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !. Virtual Congress 2020 – French programme 2020: Part I
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Exploration de la fonction respiratoire selon l'âge / Lung function testing and age
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Le roi est mort, vive le roi?
Source: Eur Respir J, 50 (1) 1701075; 10.1183/13993003.01075-2017
Year: 2017
Où en est-on dans la prise en charge de la Covid en septembre 2021 ? / Management of COVID-19: where are we ?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Où en sommes-nous dans le dépistage du cancer bronchique? Screening for lung cancer: where are we?
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Maladie thrombo-embolique: les nouvelles recommandations Thrombo-embolic disease: new recommendations
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
Démarche de prise en charge des apnées centrales du sommeil Management of central sleep apnoea
Source: International Congress 2019 – French programme 2019: Part I
Year: 2019
Coaching et prise de décision partagée dans les maladies respiratoires chroniques Coaching and shared decision-making in chronic respiratory diseases
Source: International Congress 2019 – French programme 2019: Part II
Year: 2019
Tuberculose sous toutes ses formes Tuberculosis in all its forms
Source: International Congress 2019 – French programme 2019: Part II
Year: 2019
Nouvelles perspectives thérapeutiques dans la tuberculose multi-résistanteNew perspectives in the treatment of MDR-TB
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept